Absolute Esonophil Count (AEC) PFH08
Includes:
Sample: WB-EDTA (3ml)
Methodology: Cell Counter/ Microscopy
Reporting: 11:00/19:00
Absolute Lymphocyte Count (ALC) PFH09
Includes:
Sample: WB-EDTA (3ml)
Methodology: Cell Counter/ Microscopy
Reporting: 11:00/19:00
Absolute Neutrophil Count (ANC) PFH10
Includes:
Sample: WB-EDTA (3ml)
Methodology: Cell Counter/ Microscopy
Reporting: 11:00/19:00
Absolute Reticulocyte Count (ARC) PFH11
Includes:
Sample: WB-EDTA (3ml)
Methodology: Microscopy
Reporting: Next day (11:00)
Acacia PFH12
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Acetyl Chloine Receptor Antibody (AChR) PFH13
Includes:
Sample: Serum (1 ml)
Methodology: RIA
Reporting: 3 & 6 (11:00)
Acid Fast Suspectibility - 10 drugs PFH14
Includes:
Sample: Mycobacterium Pure Culture
Methodology: BACTEC MGIT
Reporting: 3 Weeks (11:00)
Acid Fast Suspectibility - 10 drugs PFH15
Includes:
Sample: Mycobacterium Pure Culture
Methodology: L-J Method
Reporting: 8 weeks (11:00)
Acid Fast Suspectibility - 5 drugs PFH16
Includes:
Sample: Mycobacterium Pure Culture
Methodology: BACTEC MGIT
Reporting: 3 Weeks (11:00)
Acid Fast Suspectibility - 5 drugs PFH17
Includes:
Sample: Mycobacterium Pure Culture
Methodology: L-J Method
Reporting: 8 weeks (11:00)
Acid Fast Suspectibility (Rifampicin + Isoniazid) PFH18
Includes:
Sample: Mycobacterium Pure Culture/ Sputum
Methodology: Line Probe Assay
Reporting: Next Day 11:00
Acid Phosphatase - Prostatic (PAP) PFH19
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Acid Phosphatase - Total PFH20
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Activated Partial Thromboplastin Time (APTT/PTTK) PFH21
Includes:
Sample: Citrated Plasma (1ml)
Methodology: Clotting
Reporting: 11:00/19:00
Adenosine Deaminase (ADA) PFH22
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Adenosine Deaminase (ADA) PFH23
Includes:
Sample: CSF (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Adenosine Deaminase (ADA) PFH24
Includes:
Sample: Pleural Fluid (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Adenosine Deaminase (ADA) PFH25
Includes:
Sample: Ascitic Fluid (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Adenosine Deaminase (ADA) PFH26
Includes:
Sample: Pericardial Fluid (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Adenosine Deaminase (ADA) PFH27
Includes:
Sample: Pus (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Adreno Corticotrophic Hormone (ACTH) PFH28
Includes:
Sample: Plasma-EDTA (2ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
AFB Culture PFH29
Includes:
Sample: Body Fluids / CSF / Tissue /Sputum / Pus (3ml)
Methodology: BD-MGIT
Reporting: 6 weeks (11:00)
AFB Culture PFH30
Includes:
Sample: Body Fluids / CSF / Tissue /Sputum / Pus /Urine (3ml)
Methodology: L-J Method
Reporting: 8 weeks (11:00)
AFB Culture + Acid Fast Suspectibility (Rifampicin + Isoniazid) PFH31
Includes:
Sample: Urine//CSF/Body Fluids/ Pus/ Tissue in sterile container
Methodology: Bactec MGIT + Line Probe Assay
Reporting: 30 Days (11:00)
AFB stain PFH32
Includes:
Sample: Body Fluids / CSF / Sputum / Pus / Urine (3ml)
Methodology: Staining & Microscopy
Reporting: Next day (11:00)
AFB Stain (ZN Stain) PFH33
Includes:
Sample: Body Fluids / CSF / Sputum / Pus / Urine (3ml)
Methodology: Staining & Microscopy
Reporting: Next Day (11:00)
AFB/ZN Stain PFH34
Includes:
Sample: Paraffin Block
Methodology: Microscopy
Reporting: 2 days (18:00)
Alanine Transaminase (ALT/SGPT) PFH35
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Albert Stain (Diptheria Bacilli) PFH36
Includes:
Sample: Throat Swab
Methodology: Staining and Microscopy
Reporting: Next Day (11:00)
Albumin PFH37
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Albumin/Creatinine Ratio PFH38
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Alcian Blue Stain PFH39
Includes:
Sample: Any specimen/Slides
Methodology: Staining & Microscopy
Reporting: Next day (11:00)
Alcohol PFH40
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: Next day (11:00)
Alcohol PFH41
Includes:
Sample: Urine Random (25ml)
Methodology: Spectrophotometry
Reporting: Next day (11:00)
Alder PFH42
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Aldolase PFH43
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Aldosterone PFH44
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 3 & 6 (11:00)
Alkaline Phosphatase (ALP) PFH45
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Allergy AlaTOP-Adult PFH46
Includes:
Sample: Serum (2 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Allergy AlaTOP-Pediatric PFH47
Includes:
Sample: Serum (2 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Almond PFH48
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Alpha Feto Protein (AFP) PFH49
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Alpha Feto Protein (AFP) PFH50
Includes:
Sample: CSF/Body Fluid (5ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Alpha-1 Antitrypsin (AAT) PFH51
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Alterneria tenuis, PFH52
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Aluminium PFH53
Includes:
Sample: Serum/EDTA Plasma (2ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Aminolvulinic Acid (ALA) PFH54
Includes:
Sample: Urine (25 ml) & 24 hrs Urine Volume
Methodology: Column Chromatography
Reporting: 3 & 7 (11:00)
Ammonia PFH55
Includes:
Sample: Plasma- Na. Heparin (1ml)
Methodology: Spectrophotometry
Reporting: Next day (11:00)
Amphetamine PFH56
Includes:
Sample: Urine Random (5ml)
Methodology: Lateral Flow Chromotography
Reporting: 11:00/19:00
Amylase PFH57
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Amylase PFH58
Includes:
Sample: Urine (5ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Amylase PFH59
Includes:
Sample: Body Fluid (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
ANCA - Myeloperoxidase (p-ANCA) PFH60
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
ANCA - Serine Proteinase 3 (c-ANCA) PFH61
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Androstenedione (A4) PFH62
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Angiotensin Converting Enzyme (ACE) PFH63
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Anti Cyclic Citrullinated Peptide Antibody (Anti CCP) PFH64
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Anti Cysticercosis (IgG) Antibody PFH65
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 6 (11:00)
Anti ds- DNA Antibody Titres PFH66
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti ds-DNA Antibody PFH67
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Anti ds-DNA Antibody PFH68
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Jo-I antibody PFH69
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Anti Microsomal/Thryroperoxidase Antibody (AMA/Anti TPO) PFH70
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Anti Microsomal/Thryroperoxidase Antibody (AMA/Anti TPO) - Titre PFH71
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Anti Mitochondrial Antibody PFH72
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Anti Mitochondrial Antibody PFH73
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Mitochondrial Antibody Titres PFH74
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Mullerian Hormone (AMH) PFH75
Includes:
Sample: Serum/Plasma (1 ml)
Methodology: ELISA
Reporting: Next Day (11:00)
Anti Neutrophilic Cytoplasmic Antibody (ANCA) PFH76
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Neutrophilic Cytoplasmic Antibody (ANCA) Titers PFH77
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Nuclear Antibody (ANA) PFH78
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Anti Nuclear Antibody (ANA) PFH79
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Nuclear Antibody (ANA)-Titres PFH80
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Phospholipid Antibody IgG PFH81
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Anti Phospholipid Antibody IgM PFH82
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: Next day (11:00)
Anti Sm - Antibody PFH83
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Anti Smooth Muscle Antibody - Titre (ASMA) PFH84
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Smooth Muscle Antibody (ASMA) PFH85
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 2 & 4 & 1 (11:00)
Anti Soluble Liver Antigen (SLA) PFH86
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 6 (11:00)
Anti Sperm Antibody (ASAB) PFH87
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Anti SS-A/RO Antibody PFH88
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Anti SS-B/LA Antibody PFH89
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 2 & 4 & 1 (11:00)
Anti Streptolysin (ASO) - (Qualitative) PFH90
Includes:
Sample: Serum (1ml)
Methodology: Agglutination
Reporting: 11:00/19:00
Anti Streptolysin (ASO) - (Quantitative) PFH91
Includes:
Sample: Serum (1ml)
Methodology: Agglutination
Reporting: 11:00/19:01
Anti Thrombin III (Antigenic) PFH92
Includes:
Sample: NaF-Plasma (1mL)
Methodology: Nephlometry
Reporting: 11:00/19:00
Anti Thyroglobulin Antibody (ATG) PFH93
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Anti Thyroglobulin Antibody (ATG) - Titre PFH94
Includes:
Sample: Serum (1ml)
Methodology: Chemiluminescence
Reporting: 11:00/19:00
Any 3 IHC Markers PFH95
Includes:
Sample: Paraffin Blocks/ Tissue in neutral formalin
Methodology: IHC
Reporting: 10 days (18:00)
Any 5 IHC Markers PFH96
Includes:
Sample: Paraffin Blocks/ Tissue in neutral formalin
Methodology: IHC
Reporting: 10 days (18:00)
Apergillus Fumigatus PFH97
Includes:
Sample: Serum (1ml)
Methodology: Immunocap Specific IgE
Reporting: 3 days (11:00)
Apolipoprotein A1 (APO-A1) PFH98
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Apolipoprotein B (APO-B) PFH99
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Apple PFH100
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Aquaporin - 4 PFH101
Includes:
Sample: Serum (1ml)
Methodology: IFA
Reporting: 5 (11:00)
Arsenic PFH102
Includes:
Sample: WB-Heparin (3ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
Arsenic PFH103
Includes:
Sample: Urine (25ml)
Methodology: AAS/ICP-OES
Reporting: 3 days (11:00)
ASCA ( Anti Sacccharomyces Cerevisiae Antibody ) ,IgA PFH104
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 5 (19:00)
ASCA ( Anti Sacccharomyces Cerevisiae Antibody ) ,IgG PFH105
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 5 (19:00)
ASO Titres (Anti Streptolysin O) PFH106
Includes:
Sample: Serum (1ml)
Methodology: Immunoturbidometry
Reporting: 11:00/19:00
Aspartate Aminotransferase (AST/SGOT) PFH107
Includes:
Sample: Serum (1ml)
Methodology: Spectrophotometry
Reporting: 11:00/19:00
Aspergillus fumigatus, PFH108
Includes:
Sample: Serum (1 ml)
Methodology: Chemiluminescence
Reporting: 3 & 6 (11:00)
Aspergillus IgG Antibody PFH109
Includes:
Sample: Serum (1ml)
Methodology: ELISA
Reporting: 6 (11:00)
